Chemical industry: Evonik considers multi-billion dollar acquisition in the USA - Apparently no "poison pill" against BASF offer
The chemical group is not only a takeover target, but is itself on a shopping tour. According to information from the Handelsblatt, the group has been examining a possible large deal for months.
We haven't written up this one. Handelsblatt has the full story — the link below goes straight to it.